Introduction
============

The transcription factor *Phox2b* is a master regulator of the embryonic development of the autonomic nervous system and, especially, of respiratory circuits (Goridis et al., [@B20]). *Phox2b* is expressed by afferent pathways from O~2~-sensitive peripheral chemoreceptors, by chemoresponsive projections of the nucleus tractus solitarius to the ventrolateral medulla, and by central chemoreceptors located in the retrotrapezoid nucleus (RTN; Abbott et al., [@B1]). In humans, mutations in the *Phox2b* gene have been determined to cause Congenital Central Hypoventilation Syndrome (CCHS), which is characterized by hypoventilation during sleep and impaired chemosensitivity (Amiel et al., [@B4]). Knock-in mice harboring *Phox2b* mutations identified in CCHS patients display apneas and a lack of responsiveness to hypercapnia, and die soon after birth (Dubreuil et al., [@B12]). These mice show a specific loss of CO~2~-sensitive cells in the RTN (Dubreuil et al., [@B12]). *Phox2b* mutant embryos, in which RTN neurons are specifically depleted, display a reduced phrenic burst frequency and an impaired response to acidification (Dubreuil et al., [@B13]). Newborn mice carrying one invalidated *Phox2b* allele (*Phox2b*^+/−^ mice) show sleep apneas (Durand et al., [@B14]) and reduced sensitivity to hypercapnia (Dauger et al., [@B11]; Ramanantsoa et al., [@B43]). Taken together, these studies demonstrate the important role of *Phox2b* in the postnatal control of breathing.

In newborns, ventilatory control is tightly coupled with thermoregulation. This coupling allows the fine-tuning of O~2~ demand and supply, and enables the organism to cope with metabolic challenges (Mortola, [@B34]; Steiner and Branco, [@B48]; Chardon et al., [@B7]; Gargaglioni et al., [@B18]). In particular, newborns respond to oxygen demand by increasing ventilation, and then, if the demand persists, by decreasing the metabolic rate, thermogenesis and ventilation, an effect designated "hypoxic hypometabolism" (Frappell et al., [@B16], [@B17]; Mortola, [@B34], [@B35]; Bollen et al., [@B5]). The decrease in thermogenesis reflects a centrally regulated response rather than the mere limitation of oxygen availability (Mortola and Gautier, [@B37]; Gautier, [@B19]; Osaka, [@B38]). Hypoxic hypometabolism is regarded as an important response for the protection of vital organs, especially the brain, from hypoxic stress during the neonatal period. The mechanisms underlying the coupling between ventilatory control and thermoregulation are still elusive (see Osaka, [@B38] for a recent review). Our present hypothesis is that *Phox2b*, which regulates the development of neuronal circuits underlying both functions, may be important to their combined control in newborns.

The aim of the present study was to assess the role of *Phox2b* in thermoregulation and ventilatory control in newborns. To this end, we measured ventilatory and thermoregulatory responses to hypoxic stress in *Phox2b*^+/−^ newborn mouse pups. We exposed 6-day-old *Phox2b*^+/−^ pups and their wild-type littermates (*Phox2b*^+/+^) to chemical stimuli (hypoxia or hypercapnia) under cold or thermoneutral conditions. All variables were measured non-invasively in unrestrained pups to avoid any confounding effect of behavioral stress. Finally, since serotonergic neurons depend on *Phox2b* for their differentiation (Jacob et al., [@B28]) and are closely involved in respiratory function and in the thermogenic response to cold (Hilaire et al., [@B22]; Hodges and Richerson, [@B25]; Madden and Morrison, [@B31]), we explored the role of serotonin (5-HT) in the above process by measuring brain levels of the neurotransmitter.

Materials and Methods
=====================

Animals
-------

The generation and genotyping of *Phox2b*^+/−^ mice have been described elsewhere (Pattyn et al., [@B39]). Since respiratory control disorders are frequent in preterm infants and represent a major risk of brain hypoxia, we conducted this study in 6-day-old pups. This postnatal age roughly corresponds to 35 weeks of gestation in humans in terms of central nervous system development (Hagberg et al., [@B21]). Mice were housed at 21°C with a 12-h light/dark cycle (lights on at 7 a.m.) and fed *ad* *libitum*. The animals were randomly assigned to four experimental groups: hypoxia at 26°C, hypoxia at 33°C, hypercapnia at 26°C and hypercapnia at 33°C. Each litter was assigned to one experimental group. All quantifications were performed blind regarding the genotypes, which were determined after all tests were completed. Previous experiments in newborn mice (Bollen et al., [@B5]) indicated that the physiological responses to cold showed a large interindividual variability, which required a larger sample size in this condition.

Experimental protocols were approved by the Institutional Review Committee. All animal tests were performed in accordance with the European Communities Council Directive (86/809/EEC) regarding the care and use of animals for experimental procedures, in compliance with the regulations of the *Ministère de l*'*Agriculture et de la Forêt*, *Service Vétérinaire de la Santéet de la Protection Animale* (permission \# A 94-028-21). All efforts were made to minimize animal suffering, especially by using fully non-invasive functional tests.

Plethysmography
---------------

Breathing variables were measured non-invasively using a battery of four whole-body flow barometric plethysmography, allowing the simultaneous measurement of breathing variables as previously described (Bollen et al., [@B5]). We used whole-body flow barometric plethysmography, rather than head-out plethysmography which provides a relatively direct measure of breathing, to avoid the stress related to restraint. Whole-body flow barometric plethysmography provides semiquantitative measurements of tidal volume and ventilation, and valid measurements of breathing frequency and apnea. Despite these limitations, this latter technique remains the only non-invasive method for studying unrestrained newborn mice.

Each plethysmograph was composed of two 50 ml Plexiglas chambers, immersed in a water-bath to maintain their temperature at 26 or 33°C. A 200 ml min^−1^ flow of dry air (Brooks airflow stabilizer, Urlo, Holland) was divided into two 100 ml min^−1^ flows through the chambers. The differential pressure between the chambers (DRUCK--EFFA transducer, Asnières, France) was filtered (bandwidth: 0.15--20 Hz at −3 dB), converted into a digital signal at a sampling rate of 100 Hz, and processed (Labview, National Instruments, Austin, TX, USA). Calibration was done before each session using a built-in pump incorporating a microsyringe (Ito corporation, Fuji, Japan), which injected a sinusoidal airflow with a maximum amplitude of 2 μl and a frequency of 8 Hz into the animal chamber. The limitations of the plethysmographic method in newborn mice (Enhorning et al., [@B15]; Mortola and Frappell, [@B36]) have been discussed elsewhere (Lofaso et al., [@B30]). Because of these limitations, the absolute values given for the tidal volume (*V*~T~) and ventilation (*V*~E~) are indicative only, whereas the absolute values for breath duration (*T*~TOT~) and the duration of apnea, as well as the relative changes from baseline of *V*~T~, *T*~TOT~, and *V*~E~, are reliable.

Breathing variables
-------------------

*T*~TOT~ (s), *V*~T~ (μl g^−1^ BTPS), and *V*~E~ (calculated as *V*~T~ *T*~TOT~^−1^ and expressed in μl s^−1^ g^−1^ BTPS) were calculated from apnea-free periods (see apnea determination below). Breath-by-breath values for *V*~E~, *V*~T~, and *T*~TOT~ were averaged over consecutive 30 s periods. The baseline levels of these variables were calculated as the mean level during the 3-min of air breathing that preceded exposure to hypoxia or hypercapnia. The time course of *V*~E~ in response to hypoxia or hypercapnia was expressed as the percentage of change of *V*~E~ (Δ*V*~E~) over consecutive 30 s periods during the 3-min of hypoxia or 6 min of hypercapnia, relative to the last 30 s of air breathing that preceded gaseous exposure. The ventilatory response to hypoxia was also expressed as the percentage change in *V*~E~ relative to the average baseline *V*~E~, using the formula 100·(peak-*V*~E~ − baseline *V*~E~)/baseline *V*~E~. The peak-*V*~E~ response to hypoxia was determined individually as the highest of the 6 mean-*V*~E~ values (calculated over 30 s) during the 3-min hypoxic exposure. This method took into account possible interindividual differences in the delay to the peak-*V*~E~ response to hypoxia. We determined the *V*~T~ and *T*~TOT~ responses to hypoxia using the same formula, using *V*~T~ and *T*~TOT~ values measured at peak-*V*~E~. The peak-*V*~E~ response to hypercapnia was calculated along the same lines. Similarly, HVD was assessed as the maximal decrease of *V*~E~ in response to hypoxia. We previously reported that *V*~E~ started to decrease during hypoxia, about 90 s after the switch to hypoxia, but it invariably reached its minimum value over the 3-min period following the switch back to air (Bollen et al., [@B5]). Although we termed this response HVD, we cannot discard that it involved after effects of hypoxia, i.e., post-hypoxic ventilatory decline (PHVD). HVD and PHVD basically reflect the same neuronal inhibitory mechanisms, the difference being that PHVD is maximally expressed when the excitatory component of the response to hypoxia is no longer present (Coles and Dick, [@B8]).

Apneas were defined as ventilatory pauses longer than twice the duration of the preceding breath (Sawnani et al., [@B47]). Total apnea duration was calculated over successive 30 s periods. The apnea response to hypoxia was expressed as the absolute difference between total apnea duration during hypoxia and the same measurement for the 30-s period preceding hypoxia. Percentages were not calculated as some mice had no apneas during normoxia, especially at 26°C.

Heart rate
----------

In a separate experiment, we measured the heart rate (HR) in unrestrained pups. The plethysmographic chambers were equipped with recording platforms composed of four rectangular gold electrodes insulated from one another and embedded in the floor of the chamber, as previously described (Ramanantsoa et al., [@B43]). Conduction was enhanced using electrode hydrogel (Sekisui Plastics Co., Ltd., Nara, Japan). Signals were digitized at a sampling rate of 1000 Hz (16 bits, PCI-6229, National Instruments, Austin, TX, USA). An ECG signal was obtained when at least three paws were in contact with three different electrodes or, occasionally, when the pup was lying down on the floor. HR was determined from R--R wave peaks after visual selection of continuous ECG segments of 1 s or more with clearly defined QRS waves.

Ultrasonic vocalizations
------------------------

Ultrasonic vocalizations (USVs) were recorded using an ultrasound bat detector, D230 (Petterson Elektronik AB, Uppsala, Sweden), as previously described (Bollen et al., [@B5]).

Ventilatory tests
-----------------

After 15 min of normoxia, hypoxia was achieved by switching the airflow through the plethysmograph to 10% O~2~ + 90% N~2~ at the same flow rate (100 ml min^−1^ per chamber) for 3 min, after which the flow was switched back to normoxia for 12 min (total duration of the session: 30 min). Hypercapnia was achieved by switching the airflow through the plethysmograph to 8% CO~2~ + 21% O~2~ + 71% N~2~ for 6 min, after which the flow was switched back to normoxia for 9 min (total duration of the session: 30 min). We used a longer CO~2~ stimulus, compared to hypoxia, because the *V*~E~ response to 8% CO~2~ reaches its peak-value only after 2--3 min of stimulation in newborn mice (Ramanantsoa et al., [@B43]).

Thermal challenge
-----------------

Experiments were conducted at 33 or at 26°C by controlling the temperature of the water surrounding the plethysmographic chambers. Previous analysis in newborn mice has indicated that a temperature of 26°C elicits near-maximal thermogenesis by brown adipose tissue, and may therefore be considered as extreme cold (Bollen et al., [@B5]). In contrast, 33°C approaches thermoneutrality and corresponds to the temperature within litters of newborn mice in contact with their mother (Renolleau et al., [@B45]).

Body temperature
----------------

We directly measured interscapular skin temperature in all pups in the study, before and immediately after plethysmographic recording, by placing a thermocouple probe at the level of the interscapular region. In a separate experiment, we also measured the emission of infrared (IR) radiation from the skin surface of the interscapular region in the cold, as previously described (Bollen et al., [@B5]). This was done using an infrared camera (FLIR Systems Thermovision A20, Boston, MA, USA) which was mounted over one of the plethysmograph animal chambers. IR measurement was done through a special window of the plethysmograph chamber made of Zinc Selenide, to ensure permeability to IR emission.

O~2~ consumption
----------------

In a separate experiment, we measured the time course of O~2~ consumption (corrected for body weight, μl min^−1^ g^−1^) in pups exposed to hypoxia (hypercapnia elicits no metabolic response in newborns; Saiki and Mortola, [@B46]; Putnam et al., [@B41]) in cold and thermoneutral conditions. To do this, we used a method described previously (Bollen et al., [@B5]). A fan was placed in the chamber to stir the ambient gas and ensure constant washout kinetics regardless of the position of the pup. This method allowed the calculation of the time course of O~2~ consumption in conditions of variable FiO~2~. However the fan disrupted the ventilatory signal, precluding the calculation of the V~E~/VO~2~ ratio. We calculated a rough estimation of this ratio within each genotype on subgroups of the hypoxic experiment weight-matched to the VO~2~ experiment groups. To do this, we divided individual *V*~E~ values by the value of VO~2~ of the corresponding genotype group over the same periods (3-min preceding hypoxia, time of the peak-*V*~E~ response to hypoxia, and time of the minimum *V*~E~ response to hypoxia).

Analysis of serotonergic metabolism
-----------------------------------

Brains were dissected and kept at −80°C until analysis as previously reported (Ramirez and Viemari, [@B44]). Brain levels of serotonin (5-HT), its precursor [l]{.smallcaps}-tryptophan ([l]{.smallcaps}-Trp) and its main 5-HT metabolite from the monoamine oxidase A (MAOA) degradation pathway, 5-hydroxyindoleacetic acid (5-HIAA), were measured using high pressure liquid chromatography (HPLC) and electrochemical detection (Waters System: pump P510, electrochemical detector EC2465; Atlantis column DC18; mobile phase: citric acid, 50 mM; orthophosphoric acid, 60 mM; sodium octanesulfonic acid, 0.112 mM; EDTA: 0.06 mM, methanol; pH 3.01).

Statistics
----------

All respiratory variables were averaged over consecutive 30 s periods and subjected to analysis of variance with genotype (*Phox2b*^+/−^ versus wild-type *Phox2b*^+/+^) and temperature (26 versus 33°C) as the between-subjects factors. Litter had no significant effect, neither as a main between-factor nor in interaction with other factors analyzed, and will not be mentioned further. We also conducted complementary analyses using weight-matched groups to determine whether any differences between *Phox2b*^+/+^ and *Phox2b*^+/−^ pups were related to weight. Since all analyses yielded the same statistical results as those obtained using the entire population, this variable will not be mentioned further. In all tests, a *p*-value of ≤0.05 was considered to indicate a significant difference. Group means compared by ANOVA are presented along with SD in the text and the tables. SEM are used in the figures for the sake of clarity. All statistical analyses were conducted using StatView 5 (Abacus Concepts, Berkeley, CA, USA).

Results
=======

Greater temperature drop in the cold in *Phox2b*^+/−^ pups
----------------------------------------------------------

*Phox2b*^+/−^ pups weighed significantly less than their wild-type littermates (Table [1](#T1){ref-type="table"}). Before plethysmography, body temperatures measured (with a thermocouple) immediately after taking the pup from the litter were highly similar in Phox2b^+/−^ and *Phox2b*^+/+^ pups (Table [1](#T1){ref-type="table"}). In contrast, when exposed to 26°C, body temperatures (measure by infrared thermography) were lower in *Phox2b*^+/−^ pups than in their *Phox2b*^+/+^littermates, in both hypoxic and hypercapnic studies (Figure [1](#F1){ref-type="fig"}). Thus, *Phox2b*^+/−^ pups showed a reduced ability to maintain body temperature in the cold.

###### 

**Weight and temperature of 6-day-old *Phox2b*^+/−^ and *Phox2b*^+/+^ mice**.

                          33°C         26°C         G × *T*                                                         
  ----------------------- ------------ ------------ ---------- -------------------- -------------------- ---------- ----------
  **HYPOXIA STUDY**                                                                                                 
  *n*                     41           43                      84                   85                              
  Weight (g)              3.4 (0.5)    2.8 (0.4)    \<0.0001   3.7 (0.6)\*          3.0 (0.5)\*          \<0.0001   NS
  *T*° initial (°C)       33.9 (1.1)   33.7 (1.0)   NS         33.5 (1.5)           33.3 (1.4)           NS         NS
  *T*° final (°C)         34.8 (0.6)   34.6 (0.7)   NS         30.5 (1.1)\*\*\*\*   29.8 (1.4)\*\*\*\*   \<0.0003   \<0.0608
  *T*° chamber (°C)       33.0 (0.3)   33.0 (0.3)   NS         26.0 (0.3)           26.0 (0.2)           NS         NS
  *T*° infrared (°C)      --           --                      31.8 (0.6)           30.8 (1.1)           0.0001     --
  **HYPERCAPNIA STUDY**                                                                                             
  *n*                     34           36                      51                   45                              
  Weight (g)              3.7 (0.5)    3.4 (0.7)    \<0.0439   3.7 (0.5)            3.3 (0.7)            0.0006     NS
  *T*° initial (°C)       34.3 (1.1)   34.4 (1.2)   NS         34.1 (1.4)           33.7 (1.4)\*         NS         NS
  *T*° final (°C)         34.8 (1.2)   34.9 (0.8)   NS         30.8 (1.0)\*\*\*\*   30.4 (0.8)\*\*\*\*   0.0321     NS
  *T*° chamber (°C)       33.0 (0.4)   32.9 (0.4)   NS         26.2 (0.4)           26.2 (0.4)           NS         

*Weight and interscapular skin temperature were measured immediately after taking the pup from the litter (*T*° initial). The *p*-value refers to the comparison between *Phox2b*^+/+^ and *Phox2b*^+/−^ groups. Comparison of 33 versus 26°C for each genotype group; \**p* \< 0.05; \*\*\*\**p* \< 0.0001. Values indicate mean (SD) for each group. G × *T*: *p*-value for Genotype by Temperature interaction. Note that G × *T* interactions were marginally significant in the hypoxic study and therefore that genotype-related differences in final temperatures are unwarranted. Infrared temperature were not measured at 33°C, due to the lack of infrared image of the pup in thermoneutral conditions*.

![**Body temperature (*T*~b~) in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups exposed to hypoxia \[(A,B) 10% O~2~, shaded, 20 *Phox2b*^+/+^, and 31 *Phox2b*^+/−^ pups\] or hypercapnia \[(C,D) 8% CO~2~, shaded, 12 *Phox2b*^+/+^, and 20 *Phox2b*^+/−^ pups\] at an ambient temperature of 26°C**. Body temperature was measured at the level of interscapular brown adipose tissue by infrared thermography. Values are absolute levels **(A,C)** and relative changes from pre-stimulus levels **(B,D)**. Body temperature progressively decreased, revealing an inability to maintain core temperature, especially in *Phox2b*^+/−^ pups **(A,C)**. Both hypoxic and hypercapnic stimuli induced a reduction in body temperature **(A,C)**. Hypoxia induced similar temperature losses in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups, but temperature recovery long after the return to normoxia was blunted only in *Phox2b*^+/−^ pups **(B)**. In contrast, the temperature loss after hypercapnia was blunted in *Phox2b*^+/−^ pups **(D)**. Values indicate means ± SEM for the group.](fphys-02-00061-g001){#F1}

Depressed baseline ventilation in the cold in *Phox2b*^+/−^ pups
----------------------------------------------------------------

At 33°C, baseline normoxic *V*~E~ values were highly similar in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups (Table [2](#T2){ref-type="table"}). The cold stimulated *V*~E~ in both genotype groups, although this effect was significantly lower in *Phox2b*^+/−^ pups (Table [2](#T2){ref-type="table"}). This difference was further supported by apnea analysis. Apnea duration was longer in *Phox2b*^+/−^ than in *Phox2b*^+/+^ pups both at 33 and at 26°C (Table [2](#T2){ref-type="table"}). Whereas the effect of the cold on apnea duration in *Phox2b*^+/+^ pups was minimal, it significantly increased apnea duration in *Phox2b*^+/−^ pups (Table [2](#T2){ref-type="table"}). Thus, the ventilatory response to cold was markedly disrupted in *Phox2b*^+/−^ pups. The HR was diminished by the cold in both groups, without significant genotype-related differences. Behaviorally, the cold similarly stimulated movement and USV generation in *Phox2b*^+/−^ and *Phox2b*^+/+^ pups (Table [2](#T2){ref-type="table"}), suggesting that the perception of cold was not altered in *Phox2b*^+/−^ pups.

###### 

**Baseline cardiorespiratory variables**.

                            33°C            26°C           G × *T*                                                            
  ------------------------- --------------- -------------- --------- ----------------------- --------------------- ---------- ----------
  *n*                       75              79                       135                     130                              
  *V*~E~ (μl s^−1^ g^−1^)   16.3 (2.3)      16.3 (2.5)     NS        29.8 (10.8)\*\*\*\*     21.5 (11.7)\*\*\*\*   \<0.0001   \<0.0001
  *V*~T~ (μl g^−1^)         5.4 (0.6)       5.6 (0.8)      NS        8.6 (1.70)\*\*\*\*      7.9 (2.8)\*\*\*\*     0.0098     \<0.0148
  *T*~TOT~ (s)              0.34 (0.1)      0.35 (0.1)     NS        0.3 (0.1)               0.4 (0.1)\*\*\*\*     \<0.0001   \<0.0001
  Apneas (s)                0.3 (0.3)       0.7 (1.1)      0.0024    0.2 (1.2)               2.3 (4.4)\*\*\*       \<0.0001   \<0.0011
  MVT (s)                   2.0 (2.8)       1.91 (2.9)     NS        2.6 (3.5)               3.4 (4.3)\*\*         NS         NS
  USV (s)                   0.02 (0.07)     0.02 (0.04)    NS        0.51 (0.57)\*\*\*\*     0.48 (0.65)\*\*\*\*   NS         NS
  VO~2~ (ml/min/g) *n*      43.9 (13.3) 8   38.6 (7.1) 5   NS        71.8 (5.8)\*\*\*\* 10   52.4 (19.2) 17        \<0.0049   NS^†^
  HR (bpm) *n*              511 (68) 27     492 (64) 22    NS        461 (60)\*\*\* 57       453 (70)\* 61         NS         NS

*Values indicate mean (SD) for each group, calculated over the 3-min preceding the hypoxic or hypercapnic stimulus. Apnea, MVT, USV = total apnea, movement duration, and ultrasonic vocalization(s) over 30 s periods, respectively. HR: heart rate (beats min^−1^). Comparison of 33 versus 26°C for each genotype group; \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001; \*\*\*\**p* \< 0.0001; *p*-value refers to the comparison between *Phox2b*^+/+^ and *Phox2b*^+/−^ groups. G × *T*: *p*-value for Genotype by Temperature interaction. ^†^!:complete analysis of VO~2~ over the entire air period yielded significant interaction (see text). Oxygen consumption (VO~2~) and heart rate (HR) studies were conducted on separate groups of mice. The estimated V~E~/VO~2~ ratios on weighted matched subgroups indicated a significant difference between *Phox2b*^+/+^ and *Phox2b*^+/−^ groups at 33°C \[20.78 (1.92), *n* = 11, versus 38.77 (3.88), *n* = 22, *p* \< 0.0001\], but not at 26°C \[29.31 (8.29), *n* = 44 versus 27.37 (10.21), *n* = 56, NS\]*.

Abnormal ventilatory response to hypoxia in the cold in *Phox2b*^+/−^ pups
--------------------------------------------------------------------------

At 33°C, the ventilatory response to hypoxia displayed similar trends in the *Phox2b*^+/+^ and *Phox2b*^+/−^ groups (Figure [2](#F2){ref-type="fig"}A), despite small but significant differences in the peak hyperpneic *V*~E~ response and in the HVD (Table [3](#T3){ref-type="table"}). In both genotype groups, the cold depressed the *V*~E~ response to hypoxia compared to 33°C conditions, leading to reduced hyperpneic responses and an increased HVD (Figure [2](#F2){ref-type="fig"}B; Table [3](#T3){ref-type="table"}). However, these effects of the cold were less marked in *Phox2b*^+/−^ than in *Phox2b*^+/+^ pups (Figures [2](#F2){ref-type="fig"}A,B; Table [3](#T3){ref-type="table"}). As a result, in the cold, *Phox2b*^+/−^ pups showed a larger hyperpneic response to hypoxia than *Phox2b*^+/+^ pups, due mostly to the greater drop in *T*~TOT~ (Figure [2](#F2){ref-type="fig"}B; Table [3](#T3){ref-type="table"}). In line with their stronger hyperpneic response, the HVD in *Phox2b*^+/−^ pups was depressed when compared to *Phox2b*^+/+^ pups (Figure [2](#F2){ref-type="fig"}B; Table [3](#T3){ref-type="table"}). Estimated V~E~/VO~2~ ratios at the time of the peak-*V*~E~ response to hypoxia were larger in *Phox2b*^+/−^ pups, compared to *Phox2b*^+/+^ pups at both temperatures (33°C: 214 ± 22 versus 85 ± 11, *p* \< 0.0001; 26°C: 52 ± 24 versus 38 ± 10, *p* \< 0.0001). In contrast, estimated V~E~/VO~2~ ratios were smaller in *Phox2b*^+/−^ pups, compared to *Phox2b*^+/+^ during HVD (33°C: 15 ± 1 versus 17 ± 1, *p* \< 0.0006; 26°C: 22 ± 9 versus 32 ± 10, *p* \< 0.0001).

![**Ventilatory responses to hypoxia (10% O~2~, shaded) in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups at 33°C (A) and 26°C (B)**. *V*~E~: ventilation; *T*~TOT~: breath duration; *V*~T~: tidal volume. Apnea: total apnea duration/30 s. Values are expressed as percentage changes from pre-hypoxic levels for *V*~E~, *V*~T~, and *T*~TOT~. Apnea durations are expressed as absolute changes from pre-hypoxic levels. Latency to peak-*V*~E~ from the onset of hypoxia shows wide interindividual variability (see Table [3](#T3){ref-type="table"}), which smoothens the difference between the mean-*V*~E~ curves. At 33°C, breathing variables are similar in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups, although *Phox2b*^+/−^ pups have a slightly smaller *V*~E~ response to hypoxia (see Table [3](#T3){ref-type="table"} for statistical analyses). The HVD is more sustained in *Phox2b*^+/−^ pups than in *Phox2b*^+/+^ pups exposed to cold. Values indicate means ± SEM for each group. See Table [1](#T1){ref-type="table"} for group sizes.](fphys-02-00061-g002){#F2}

###### 

**Ventilatory responses to hypoxia and hypercapnia**.

                                            33°C       26°C       G × *T*                                                    
  ----------------------------------------- ---------- ---------- --------- ------------------ ------------------ ---------- ----------
  **PEAK-*V*~E~ RESPONSE TO HYPOXIA**                                                                                        
  *n*                                       41         43                   84                 85                            
  Δ*V*~E~ (%)                               95 (22)    80 (17)    0.0011    29 (19)\*\*\*\*    51 (33)\*\*\*\*    \<0.0001   \<0.0001
  Δ*V*~T~ (%)                               32 (14)    27 (12)    NS        13 (13)\*\*\*\*    23 (21)            0.0004     \<0.0009
  Δ*T*~TOT~ (%)                             −32 (7)    −29 (8)    NS        −12 (8)\*\*\*\*    −18 (10)\*\*\*\*   0.0001     \<0.0003
  Peak-*V*~E~ latency (s)                   143 (29)   148 (30)   NS        99 (41)\*\*\*\*    110 (44)\*\*\*\*   NS         NS
  **HYPOXIC VENTILATORY DECLINE**                                                                                            
  *n*                                       41         43                   84                 85                            
  Δ*V*~E~ (%)                               −11 (7)    −7 (9)     0.0173    −33 (12)\*\*\*\*   −25 (18)\*\*\*\*   0.0007     NS
  Δ*V*~T~ (%)                               −12 (10)   −8 (9)     NS        −23 (10)\*\*\*\*   −17 (13)\*\*\*     0.0021     NS
  Δ*T*~TOT~ (%)                             0 (14)     −1 (14)    NS        18 (20)            13 (17)            NS         NS
  **PEAK-*V*~E~ RESPONSE TO HYPERCAPNIA**                                                                                    
  *n*                                       34         36                   51                 45                            
  Δ*V*~E~ (%)                               150 (62)   118 (70)   0.0489    96 (47)\*\*\*\*    121 (71)           0.0436     \<0.0044
  Δ*V*~T~ (%)                               98 (23)    83 (30)    0.0300    81 (30)\*\*        89 (44)            NS         \<0.0314
  Δ*T*~TOT~ (%)                             −19 (12)   −13 (13)   0.0346    −4 (14)\*\*\*\*    −11 (18)           0.0440     0.0050
  Peak-*V*~E~ latency (s)                   294 (65)   292 (59)   NS        194 (71)\*\*\*\*   250 (90)\*         0.0010     0.0129

*Values are percentage changes from pre-stimulus values. The peak-*V*~E~ response to hypoxia and hypoxic ventilatory decline were calculated individually over the entire 3 min of hypoxia and the 3-min post-hypoxic period, respectively. The peak-*V*~E~ response to hypercapnia was calculated over the entire 6 min of hypercapnia. Values indicate mean (SD) for each group. The *p*-value refers to the comparison between *Phox2b*^+/+^ and *Phox2b*^+/^ groups. Comparison of 33 versus 26°C for each genotype group; \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001; \*\*\*\**p* \< 0.0001. G × *T*: *p*-value for Genotype by Temperature interaction. Note that the G × *T* interaction was marginally significant for *V*~T~*.

Apneas were nearly absent and showed no significant changes in response to hypoxia in *Phox2b*^+/+^ pups at either temperature. In contrast, apneas occurred in *Phox2b*^+/−^ pups, and showed longer total durations than in *Phox2b*^+/+^ pups, especially in the cold; apneas markedly decreased in response to hypoxia, and then markedly increased during the HVD (Figure [2](#F2){ref-type="fig"}B). However, total apnea duration remained low in *Phox2b*^+/−^ pups (\<3 s out of 30 s; Figure [2](#F2){ref-type="fig"}B).

Disrupted VO~2~ response to cold in *Phox2b*^+/−^ pups
------------------------------------------------------

Firstly, due to their complex pattern, VO~2~ data were analyzed over the entire normoxic periods in cold and thermoneutral conditions (Figure [3](#F3){ref-type="fig"}). The comparison of the time courses of VO~2~ between Phox2b^+/−^ and Phox2b^+/+^ pups yielded different results at 33 and 26°C (Genotype by Temperature by Time interaction, *p* \< 0.0001). At 33°C, the time courses of VO~2~ were similar in Phox2b^+/−^ and Phox2b^+/+^ pups (Genotype by Time interaction: NS; Figure [3](#F3){ref-type="fig"}A). In contrast, at 26°C, these time courses were markedly different in Phox2b^+/−^ and Phox2b^+/+^ pups, due to smaller VO~2~ increase and steady state in *Phox2b*^+/−^ pups (Genotype by Time interaction, *p* \< 0.0001; Figure [3](#F3){ref-type="fig"}C; Table [2](#T2){ref-type="table"}). Thus, the VO~2~ response to cold was markedly altered in *Phox2b*^+/−^ pups. The reduced VO~2~ response to cold in *Phox2b*^+/−^ pups is in line with their lower body temperatures and *V*~E~ (Table [2](#T2){ref-type="table"}).

![**Oxygen consumption (VO~2~) in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups exposed to hypoxia (10% O~2~, shaded) at 33°C \[(A,B) *Phox2b*^+/+^: *n* = 8 and *Phox2b*^+/−^: *n* = 5\] and at 26°C \[(C,D) *Phox2b*^+/+^: *n* = 10 and *Phox2b*^+/−^: *n* = 17)**. Values are absolute levels **(A,C)** and relative changes from pre-hypoxic levels **(B,D)**. Regardless of temperature, hypoxia depresses VO~2~ in both genotype groups. At 33°C, the drop in VO~2~ is larger in *Phox2b*^+/−^ pups. At 26°C, the VO~2~ response to hypoxia is markedly altered in *Phox2b*^+/−^ compared to *Phox2b*^+/+^ pups. Values indicate means ± SEM for each group.](fphys-02-00061-g003){#F3}

Disrupted hypoxic hypometabolism in *Phox2b*^+/−^ pups
------------------------------------------------------

The analysis of VO~2~ response to hypoxia (especially when expressed as percent changes from pre-hypoxic levels) yielded different results in *Phox2b*^+/−^ and *Phox2b*^+/+^ pups (Genotype by Temperature by Time interaction, *p* \< 0.0001; Figures [3](#F3){ref-type="fig"}B,D). At 33°C, the magnitude of the drop in VO~2~ (relative to pre-hypoxic levels) was greater in *Phox2b*^+/−^ pups than in wild-type controls although this difference was not significant (Genotype by Time interaction: NS; Figure [3](#F3){ref-type="fig"}B). In contrast, at 26°C, the entire pattern of VO~2~ changes was altered in *Phox2b*^+/−^ pups, so that the time course of VO~2~, relative to pre-hypoxic levels, was practically in phase opposition between *Phox2b*^+/−^ and *Phox2b*^+/+^ pups (Genotype by Time interaction: *p* \< 0.0001; Figure [3](#F3){ref-type="fig"}D). These results indicate that the metabolic response to the cold and hypoxia was profoundly affected by the Phox2b mutation.

Abnormal ventilatory response to hypercapnia in the cold in *Phox2b*^+/−^ pups
------------------------------------------------------------------------------

At 33°C, the *V*~E~ response to hypercapnia was significantly reduced in *Phox2b*^+/−^ than in *Phox2b*^+/+^ pups, as previously reported (Dauger et al., [@B11]; Durand et al., [@B14]; Ramanantsoa et al., [@B43]). This difference in *V*~E~ was due to lower responses in both *T*~TOT~ and *V*~T~, but mostly *V*~T~, in *Phox2b*^+/−^ pups (Figures [4](#F4){ref-type="fig"}A,B; Table [3](#T3){ref-type="table"}).

![**Ventilatory responses to hypercapnia (8% CO~2~, shaded) in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups at 33°C (A) and 26°C (B)**. See legend of Figure [2](#F2){ref-type="fig"} for abbreviations. At 33°C, the *V*~E~ response to hypercapnia was significantly lower in *Phox2b*^+/−^ pups compared to *Phox2b*^+/+^ pups. This difference was reversed at 26°C, due to the lack of a hypercapnic ventilatory decline in *Phox2b*^+/−^ pups. Values indicate means ± SEM for each group. See Table [1](#T1){ref-type="table"} for group sizes.](fphys-02-00061-g004){#F4}

The cold depressed the ventilatory response to hypercapnia in *Phox2b*^+/+^ but not in *Phox2b*^+/−^ pups (Figures [4](#F4){ref-type="fig"}A,B; Table [3](#T3){ref-type="table"}). This difference was mainly due to the fact that, in the cold, *V*~E~ was reduced in *Phox2b*^+/+^ pups before the end of exposure to hypercapnia (hypercapnic ventilatory decline). In contrast, in *Phox2b*^+/−^ pups, the *V*~E~ response to hypercapnia was sustained throughout the hypercapnic stimulus (Figures [4](#F4){ref-type="fig"}A,B; Table [3](#T3){ref-type="table"}). The difference in the *V*~E~ response to hypercapnia between the two genotype groups was mainly due to differences in *T*~TOT~. The absence of a hypercapnic ventilatory decline in *Phox2b*^+/−^ pups led to a larger *V*~E~ response during the last 3 min of hypercapnic exposure in *Phox2b*^+/−^ than in *Phox2b*^+/+^ pups (Figures [4](#F4){ref-type="fig"}A,B; Table [3](#T3){ref-type="table"}).

These differences in the *V*~E~ response to CO~2~ were apparently not related to arousal. In fact, at 33°C, movement duration (MVT) and USV duration in response to hypercapnia were practically absent in both genotype groups. In the cold, the USV and MVT responses to hypercapnia were similar in both genotype groups (data not shown).

Impaired brain 5-HT metabolism in *Phox2b*^+/−^ pups
----------------------------------------------------

We found highly similar 5-HT levels in the two groups, although concentrations of [l]{.smallcaps}-Trp (a 5-HT precursor) and 5-HIAA (a 5-HT catabolite) were higher in *Phox2b*^+/−^ preparations (Table [4](#T4){ref-type="table"}). The 5-HT/5-HIAA ratio, a marker of 5-HT turnover rate, was significantly lower in *Phox2b*^+/−^ preparations (Table [4](#T4){ref-type="table"}). On the other hand, concentrations of adrenaline, dopamine and the metabolite DOPAC were very similar in *Phox2b*^+/−^ and *Phox2b*^+/+^ pups (data not shown).

###### 

**Detection of serotonin in the brains of 6-day-old *Phox2b*^+/+^ (*n* = 20) and *Phox2b*^+/−^ (*n* = 13) pups**.

                        *Phox2b*^+/+^   *Phox2b*^+/−^   *p*-Value
  --------------------- --------------- --------------- -----------
  5-HT                  5.73 (1.45)     6.41 (1.49)     0.0954
  [l]{.smallcaps}-Trp   62.65 (21.96)   82.99 (32.48)   0.0196
  5-HIAA                2.47 (0.72)     3.48 (1.14)     0.0019
  5-HT/5-HIAA           2.48 (0.84)     1.96 (0.54)     0.0288

*Serotonin (5-HT), the serotonin precursor [l]{.smallcaps}-tryptophan ([l]{.smallcaps}-Trp), and its degradation product 5-hydroxyindoleacetic acid (5-HIAA) were quantified using HPLC. Data indicate abnormal 5-HT metabolism in *Phox2b*^+/−^ pups. Contents are expressed in nanogram per gram of wet brain tissue. Values indicate mean (SD) for each group*.

Discussion
==========

The present results confirm and extend our previous findings regarding the impairment of respiratory control in *Phox2b*^+/−^ pups (Dauger et al., [@B11]; Ramanantsoa et al., [@B42], [@B43]). Under thermoneutral conditions (33°C), *Phox2b*^+/−^ pups show nearly normal baseline breathing patterns and a reduced ventilatory response to hypercapnia, and to a lesser extent, to hypoxia. More importantly, the present study reveals important impairments of the ventilatory and thermoregulatory responses to cold. In the cold, *Phox2b*^+/−^ pups show reduced normoxic ventilation and oxygen consumption (VO~2~) and a lower body temperature when compared to *Phox2b*^+/+^ pups. Furthermore, the inhibitory effects of the cold on the ventilatory responses to hypoxia and hypercapnia are blunted in *Phox2b*^+/−^ pups. Finally, these physiological impairments are associated with a modified turnover of brain 5-HT.

Impaired thermogenic responses to cold
--------------------------------------

The blunted VO~2~ and temperature responses to cold in *Phox2b*^+/−^ pups are novel findings that suggest that the phenotypic defects caused by *Phox2b* haploinsufficiency are more important than previously reported. In both genotype groups, body temperature progressively decreased in spite of constant high VO~2~ and *V*~E~ levels during exposure to cold. The increase in VO~2~ is due to the increase in oxidative metabolism caused by heat production by brown adipose tissue (Darnall et al., [@B10]). The thermogenic response to cold is a critical defensive response, present at birth (Frappell et al., [@B17]; Malik and Fewell, [@B32]) in numerous species (Maskrey, [@B33]; Cameron et al., [@B6]; Mortola, [@B35]) including mice (Bollen et al., [@B5]). Thus, *Phox2b* haploinsufficiency, which has a limited physiological impact under normal temperature conditions, may be of greater important under cold conditions. It is unclear whether these impairments are related to heat dissipation, which depends on the central control of vasomotricity and may rely on *Phox2b*-dependent structures (Pattyn et al., [@B39]).

Chemosensitivity disorders under thermoneutral conditions
---------------------------------------------------------

Ventilatory results obtained in *Phox2b*^+/−^ pups under thermoneutral conditions confirm previous observations carried out at similar ages (Dauger et al., [@B11]; Durand et al., [@B14]; Ramanantsoa et al., [@B43]). In air, *V*~E~ levels at 33°C were similar in *Phox2b*^+/+^ and *Phox2b*^+/−^ pups; however, the *V*~E~ response to hypercapnia was blunted in *Phox2b*^+/−^ pups, an effect previously shown to be present on postnatal day 2 (P2), but recovered by around P10 (Dauger et al., [@B11]). In contrast, the slightly diminished responses to hypoxia under thermoneutral conditions, both in terms of the initial hyperpneic response and the HVD, are novel findings that contrast with the stronger HVD observed on P2 (Dauger et al., [@B11]). This difference is possibly due to the fact that the resetting of peripheral chemoreceptors occurs between 6 and 12 h postnatally in mice (Renolleau et al., [@B45]). Therefore, the hyperpneic response to hypoxia is very immature in 2-day-old pups, possibly masking the effects of the *Phox2b* mutation. The impairment of the hypoxic ventilatory response could thus be related to the previously described developmental defect in petrosal chemosensory neurons (Dauger et al., [@B11]).

Ventilatory and metabolic responses to hypoxia in the cold
----------------------------------------------------------

In both genotype groups, the *V*~E~ response to hypoxia was dramatically decreased by the cold, leading to a smaller initial hyperpneic component and to larger ventilatory decline, as previously reported (Bollen et al., [@B5]). In fact, the need for increased thermogenesis in the context of reduced oxygen availability induces a shift toward metabolic depression, rather than increased ventilation (Mortola, [@B35]). This depressive effect of the cold was reduced in *Phox2b*^+/−^ pups, as shown by their larger hyperpneic responses and smaller HVD when compared to *Phox2b*^+/+^ pups.

As a rule, numerous factors contribute to the HVD: decreased inputs from the carotid bodies, central inhibitory neurotransmitters, reduced PaCO~2~, decreased metabolism (Waters and Gozal, [@B49]). Among these, a defective metabolic response to hypoxia could account for the blunted HVD in *Phox2b*^+/−^ pups. Not only was the overall VO~2~ response to the cold blunted in *Phox2b*^+/−^ pups, the decrease in VO~2~ caused by hypoxia presented major time-dependent differences between *Phox2b*^+/+^and *Phox2b*^+/−^ pups at both temperatures. Under thermoneutral conditions, the drop in VO~2~ was greater in *Phox2b*^+/−^ than in *Phox2b*^+/+^ pups. In the cold, the time course of VO~2~ in *Phox2b*^+/−^ and *Phox2b*^+/+^ pups was practically in opposite-phase, reflecting metabolic responses that were qualitatively and quantitatively different in these two groups. Although the differences in VO~2~ probably affected the ventilatory response to hypoxia in the cold, it is unlikely that they fully accounted for these genotype-related differences, a conclusion supported by the respective time courses of VO~2~ and *V*~E~ (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Although technical limitations precluded the simultaneous measurement of *V*~E~ and VO~2~, the qualitative differences between the *V*~E~ and VO~2~ responses to hypoxia in the cold and their estimated ratios suggest that the coupling between these two responses is markedly affected in *Phox2b*^+/−^ pups.

Impaired ventilatory responses to hypercapnia
---------------------------------------------

The present study confirms that the ventilatory response to hypercapnia in *Phox2b*^+/−^ pups is diminished, as previously reported (Dauger et al., [@B11]; Ramanantsoa et al., [@B43]). In *Phox2b*^+/+^ pups only, the hyperpneic response to hypercapnia was depressed in the cold, as compared to thermoneutral conditions, in line with previous results in 2-day-old mice (Ramanantsoa et al., [@B43]) and 4- to 6-day-old rats (Saiki and Mortola, [@B46]). The main consequence of the depressive effect of the cold on the *V*~E~ response to hypercapnia was that the *V*~E~ of *Phox2b*^+/+^ pups decreased after 3 min of hypercapnia, an effect that was not observed in *Phox2b*^+/−^ pups. Previous studies have reported that the expiratory duration increases slightly during sustained hypercapnia in 5-day-old rats under thermoneutral conditions, an effect ascribed to GABAergic mechanisms (Abu-Shaweesh et al., [@B2]). The mechanisms underlying the depressive effects of the cold on the ventilatory response to hypercapnia may be related to the fact that an increase in *V*~E~ would promote heat dissipation and a reduction in body temperature (Mortola, [@B35]). Thus, the abnormal metabolic response of *Phox2b*^+/−^ pups in response to cold may at least partly account for their altered response to hypercapnia when compared to *Phox2b*^+/+^ pups.

The role of 5-HT metabolism
---------------------------

Chromatographic analysis indicates that 5-HT metabolism is impaired in the brain of *Phox2b*^+/−^ pups. Whereas 5-HT levels were similar in *Phox2b*^+/−^ and *Phox2b*^+/+^ pups, the concentrations of its precursor and catabolite were higher, and the 5-HT turnover rate lower, in *Phox2b*^+/−^ preparations. The abnormal 5-HT metabolism revealed by these results might be ascribable to the impaired development of 5-HT neurons, since *Phox2b* is closely involved in the production of essential enzymes for catecholamine biosynthesis and the selection between a motoneuronal and a 5-HT neuronal fate in the embryonic central nervous system (Pattyn et al., [@B40]; Alenina et al., [@B3]; Coppola et al., [@B9]). However, it is unclear generation of 5-HT neurons was disrupted in circuits involved in thermoregulation and respiratory control. Because the present chromatographic data were collected in the whole brain, it is difficult to specifically associate 5-HT metabolism disorders and physiological disorders in *Phox2b*^+/−^ pups.

However, the putative association between 5-HT metabolism and early respiratory control disorders in *Phox2b*^+/−^ pups is in line with previous studies in newborn mice with a genetic impairment in 5-HT signaling. In particular, newborn transgenic mice lacking serotonergic neurons display severe apnea and mortality (Hodges et al., [@B27]). Transgenic mice lacking central 5-HT neurons (*Lmx1b^f/f/p^* mice) show a 50% reduction in the hypercapnic ventilatory response and insufficient heat production under cold conditions (Hodges and Richerson, [@B24]; Hodges et al., [@B26]). Adult *Pet-1* null mice, which retain 30% of their central 5-HT neurons, show gender-related impairments in baseline ventilation, hypercapnic ventilatory responses, and heat production in response to cold (Hodges et al., [@B23]). Taken together, these studies strongly support the idea that 5-HT neurons play an integrative role in the control of ventilation in response to metabolic and thermoregulatory demands, as previously proposed (reviewed in Hodges et al., [@B23]). Therefore, the impairment of 5-HT metabolism in *Phox2b*^+/−^ pups may account for their reduced ventilatory drive and disrupted hypoxic hypometabolism response to cold.

Clinical implications
---------------------

The present study suggests that *Phox2b* haploinsufficiency compromises the newborn's ability to cope with hypoxia and cold. Hypoxia is the most common cause of brain damage in newborns, and hypothermia is also associated with increased morbidity and mortality, although moderate hypothermia may be neuroprotective in infants with hypoxic-ischemic encephalopathy (Johnston et al., [@B29]). To date, the only known link between *Phox2b* mutations and physiological disorders concerns CCHS. However, the disease-causing mechanism of CCHS is not *Phox2b* haploinsufficiency (i.e., the putative consequence of the invalidation of one allele of *Phox2b*) but rather a toxic gain of function or a dominant-negative effect of a *Phox2b* polyalanine expansion (Amiel et al., [@B4]), which causes a much more severe phenotype than *Phox2b* haploinsufficiency. The analysis of the parents and family members of CCHS patients (5--10% of CCHS mutations are inherited) has revealed milder forms of CCHS than previously identified, generally due to shorter polyalanine expansions or non-polyalanine *PHOX2B* mutations (Weese-Mayer et al., [@B50]). These subclinical phenotypes suggest that *PHOX2B* mutations may induce more frequent and less severe autonomic dysregulations than those observed in CCHS. In this respect, our present results indicate that *Phox2b* mutations with mild consequences under normal conditions could nevertheless profoundly alter the physiological response to extreme conditions.

Conclusion
==========

In the present study, we show that the cold markedly alters the respiratory phenotype of *Phox2b*^+/−^ pups, as reflected by their impaired baseline ventilation and ventilatory responses to hypercapnia and hypoxia. The ventilatory impairments seen in *Phox2b*^+/−^ pups were at least partially accounted for by their reduced ability to induce thermogenic responses to cold. Thus *Phox2b* haploinsufficiency, which has mild effects on vital functions under standard conditions, may in fact profoundly alter the ability to cope with severe metabolic challenges during early postnatal development.
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